Ziebold, Carolina http://orcid.org/0000-0002-7965-6680
Evans-Lacko, Sara
Andrade, Mário César Rezende
Hoffmann, Maurício
Fonseca, Laís
Barbosa, Matheus
Pan, Pedro Mario
Miguel, Euripedes
Bressan, Rodrigo
Rohde, Luis Augusto
Salum, Giovanni
Schafer, Julia
de Jesus Mari, Jair
Gadelha, Ary
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (573974/2008-0, 465550/2014-2)
Fundação de Amparo à Pesquisa do Estado de São Paulo (2008/57896-8, 2014/50917-0)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.575201/2020-00)
Article History
Received: 13 August 2021
Accepted: 21 November 2021
First Online: 2 December 2021
Declarations
:
: CZ, SEL, MCRA, MH, LF, MB, PMP, EM, RAB, GS, JS, and JM have no conflict of interest to declare. LAR has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Aché, Bial, Medice, Novartis/Sandoz, Pfizer/Upjohn, and Shire/Takeda in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr LAR have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis/Sandoz and Shire/Takeda. Dr LAR has received authorship royalties from Oxford Press and ArtMed. AG has been a consultant and/or advisor to or has received honoraria from Aché, Daiichi-Sankyo, Torrent, Cristalia, and Janssen.
: All procedures were approved by the Ethics Committee of the Federal University of São Paulo and Hospital de Clínicas de Porto Alegre.
: Child assent and parental informed consent were obtained from all the research subjects.